Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,841,992
+$443,945 QoQ
Shares Held
26,981
-0.3% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 374 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $207,035,038 across 18 Diagnostics & Research names. GRAL ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
254,838 | $127,765,579 | |
| 2 | DHR |
Danaher Corp /De/
|
193,732 | $36,902,071 | |
| 3 | DGX |
Quest Diagnostics Inc
|
38,935 | $8,252,272 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
38,983 | $7,532,295 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
10,633 | $5,597,636 | |
| 6 | WAT |
Waters Corp /De/
|
12,321 | $4,620,866 | |
| 7 | LH |
Labcorp Holdings Inc.
|
11,342 | $3,175,760 | |
| 8 | A |
Agilent Technologies, Inc.
|
19,333 | $2,568,002 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,841,992 | 26,981 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,398,047 | 27,052 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,299,546 | 26,867 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,682,839 | 28,460 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $984,333 | 19,143 | Shares | Defined | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||